Pfizer Inc. (BMV:PFE)

Market Cap	3.08T
Revenue (ttm)	1.33T
Net Income (ttm)	167.35B
Shares Out	n/a
EPS (ttm)	29.42
PE Ratio	18.38
Forward PE	n/a
Dividend	31.96 (5.92%)
Ex-Dividend Date	Jan 24, 2025

Volume	277
Average Volume	15,987
Open	532.01
Previous Close	538.68
Day's Range	532.00 - 540.00
52-Week Range	429.00 - 597.50
Beta	0.57
RSI	53.22
Earnings Date	Feb 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and po...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 88,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 8.77% compared to the previous year's $58.50 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD